EXHIBIT 15.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Takeda Pharmaceutical Company Limited:

We consent to the incorporation by reference in the registration statement (No. 333-239409) on Form F-3 of our reports dated June 29, 2021, with respect to the consolidated financial statements of Takeda Pharmaceutical Company Limited and the effectiveness of internal control over financial reporting.

/s/KPMG AZSA LLC

Tokyo, Japan

June 29, 2021